What You Need to Know
• Johnson & Johnson has agreed to pay $5.5 billion to settle approximately 69,000 lawsuits in the United States.
• The settlement addresses claims that the company’s talc-based baby powder caused ovarian cancer among users.
• A separate case in the United Kingdom involves over 7,000 claimants alleging similar health risks from J&J’s talc products.
Johnson & Johnson (J&J) announced on July 28, 2026, that it will pay $5.5 billion to resolve around 69,000 lawsuits in the United States claiming its discontinued talc-based baby powder caused ovarian cancer. This settlement represents 99.75 percent of outstanding talc-related cases in U.S. federal and state courts and will only be finalized if accepted by 95 percent of the claimants. Although J&J maintains that there is no evidence linking talc to cancer, the World Health Organization classified talc as “probably carcinogenic to humans” in 2024. The settlement does not include a significant case in the United Kingdom, where over 7,000 claimants allege that J&J was aware of the cancer risks associated with its talc products but continued to sell them.
Why It Matters
This settlement is significant as it marks a major resolution in a decade-long series of legal battles for Johnson & Johnson regarding its talc products. The company previously faced substantial jury awards, including a $72 million verdict in 2016, which highlighted the potential health risks associated with talc. The ongoing UK case represents the largest product liability lawsuit in British history, further complicating J&J’s legal challenges. The outcome of these cases could have lasting implications for product safety regulations and corporate accountability in the pharmaceutical and consumer goods industries.
Read the Full Story →
